dantrolene oral
Selected indexed studies
- Oral dantrolene. (Anaesthesia, 2004) [PMID:15479327]
- Spasticity: pathophysiology, evaluation and management. (Pract Neurol, 2012) [PMID:22976059]
- Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients. (Anesthesiology, 1988) [PMID:3057938]
_Worker-drafted node — pending editorial review._
Connections
dantrolene oral is a side effect of
Sources
- Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. (2004) pubmed
- Oral dantrolene. (2004) pubmed
- Spasticity: pathophysiology, evaluation and management. (2012) pubmed
- Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients. (1988) pubmed
- Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia-Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability. (2023) pubmed
- Oral Dantrolene Reduces Myalgia and Hyperckemia in a Child with RYR1-Related Exertional Myalgia/Rhabdomyolysis. (2023) pubmed
- Pharmacokinetic evaluation of oral dantrolene in the dog. (2014) pubmed
- Malignant hyperthermia. (1980) pubmed
- Troyer Syndrome. (1993) pubmed
- Spastic Paraplegia 3A. (1993) pubmed